Actively Recruiting
Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2024-04-16
2800
Participants Needed
1
Research Sites
469 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To explore whether there is a significant difference in the cumulative live birth rate and maternal and child health outcomes between cancer patients who undergo or do not undergo fertility preservation before receiving anti-tumor treatment and non-cancer patients who undergo assisted reproductive technology treatment/natural pregnancy. This study will be conducted in the Clinical Center of Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University. 2800 women diagnosed with malignant cancers who has desire to reproduce will be enrolled in this study. Statistical analysis of the data will be performed.
CONDITIONS
Official Title
Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of tumor, including breast cancer, hematological disease/lymphoma, gynecological tumors (ovarian cancer), borderline tumors, nasopharyngeal cancer, colorectal cancer, or other tumors requiring anti-tumor treatment
- Desire for future fertility, including women who have already given birth
- Age between 20 and 40 years (patients freezing eggs up to 35 years old; patients freezing embryos up to 40 years old)
- Provided informed consent
You will not qualify if you...
- Congenital or acquired uterine abnormalities, severe intrauterine adhesions, or other diseases clearly impacting pregnancy
- Contraindications to assisted reproductive technology or pregnancy
- Tumors deemed unsuitable for pregnancy after multidisciplinary evaluation
- Clinical diagnosis of premature ovarian insufficiency (POI)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinical Center of Reproductive Medicine of First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China, 210000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here